Fujiyoshi Carol MD is categorized under Specialized Medical Practitioners, Except Internal in Manchester, TN .
Fujiyoshi Carol MD was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Specialized Medical Practitioners, Except Internal business, which does work in the B2C market, and is classified as a Specialized Medical Practitioners, Except Internal, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Carol Fujiyoshi at the company’s single location by writing to 822 Mcarthur St, Manchester, Tennessee TN 37355 or by phoning (931) 962-2012. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fujiyoshi Carol MD |
| Contact Person: | Carol Fujiyoshi |
| Address: | 822 Mcarthur St, Manchester, Tennessee 37355 |
| Phone Number: | (931) 962-2012 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Specialized Medical Practitioners, Except Internal |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Fujiyoshi Carol MD was started in 0 to provide professional Specialized Medical Practitioners, Except Internal under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Carol Fujiyoshi for inquiries that concern Fujiyoshi Carol MD by calling the company number (931) 962-2012, as your correspondence is most welcome. Additionally, the physical location of the single location of Fujiyoshi Carol MD can be found at the coordinates 35.47471,-86.08216 as well as the street address 822 Mcarthur St in Manchester, Tennessee 37355.
For its online presence, you may visit Fujiyoshi Carol MD’s website at and engage with its social media outlets through on Twitter and on Facebook.